… More and more nanotherapeutics with different … in injury kidneys and also directly as
effective antioxidants. Here, we discuss the recent nanotherapeutics applied in the treatment and …

… , nanotherapeutic interventions have emerged as a promising and prospective strategy for
AKI, overcoming traditional treatment … latest advancements in nanotherapeutic approaches for …

… approach for the treatment of kidney diseases. Specifically, … models of acute kidney injury
(AKI) and chronic kidney disease (… a promising nanotherapeutic strategy for AKI treatment and …

… [38] found that kidney-selective mesoscale nanoparticles (… benefit in treatment of
cisplatin-induced acute kidney injury due … atorvastatin-induced kidney injury without compromising …

… of acute kidney injury (AKI) and chronic kidney disease (CKD). … with JQ1 to enhance kidney
drug delivery and minimize side … the kidney, this therapy could be relevant in the treatment of …

… cancer treatment, saving millions of lives. However, its high risk still poses a significant
challenge for cisplatin-induced acute kidney injury (AKI), which occurs in 30% of cisplatin-treated …

… (B) Fluorescence images of major organs (heart, liver, spleen, lung and kidney) in acute
kidney injury mice treated with Cy5.5-labeled FGF21, Z@FGF21, MZ@FGF21 and KMZ@FGF21 …

… Moreover, the treatment of kidney diseases is burdened by … damage can drive further kidney
injury, producing a transition … kidney fibrosis and the development of chronic kidney disease (…

… treat acute kidney injury (AKI). Given the high prevalence and high mortality rate of AKI, the
development of drugs to effectively treat … in the field of AKI nanotherapeutics and highlight the …

… to treatment - when using NDCs for delivery to the kidney. We also highlight the need to
identify the accumulation sites of NDCs carrying reno-protective agents in renal tissues during in …